Nobilis Therapeutics is looking forward to connecting with investors, biotechnology and pharma companies at the upcoming BIO Digital Conference. The company will be updating conference participants on its recent advancements and will be discussing investment opportunities. Given the effects of COVID-19 pandemic on societal mental health the company is well positioned to accelerate its clinical development in the field of PTSD and other psychiatric disorders.
Please reach out to us at [email protected] to schedule a virtual meeting,
